Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nova Eye Medical ( (AU:EYE) ) just unveiled an update.
Nova Eye Medical Limited has announced a change in the director’s interest, specifically concerning Victor Previn. The change involves an indirect interest through Sedico Pty Ltd as trustee, with an acquisition of 416,666 ordinary securities valued at $49,999.92, approved at a general meeting on 19 March 2025. This adjustment in director’s interest reflects the company’s ongoing governance and compliance with ASX listing rules.
More about Nova Eye Medical
Technical Sentiment Signal: Buy
Current Market Cap: $16.81M
For an in-depth examination of EYE stock, go to TipRanks’ Stock Analysis page.